Brachioplasty Market Size, Share & Growth Report, 2030

Reference overview

The global brachioplasty market size was estimated at USD 1.35 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.1% from 2023 to 2030. Brachioplasty, also known as arm lift, is a surgery to reshape the back of the arm by removing excess fat and residual tissue to improve the physical appearance. The market is expected to witness growth due to several factors such as increasing weight loss surgeries, rising value of self-esteem, advancement in surgical and non-surgical techniques, growing geriatric population, and rising rates of obesity. Four in ten Americans are obese, according to the State of Obesity 2022, and obesity rates are rising both nationally and among different population groups.

The pandemic has had a negative impact on the brachioplasty market. Various voluntary patient procedures were stopped and beds were made available to patients with COVID-19. Elective cosmetic surgery was stopped for 8.1 weeks in 2020, resulting in lower patient attendance. For example, according to the American Society of Plastic Surgeons, arm lift procedures performed in the US fell 17% in 2020 from 2019. However, due to changing levels of customer perception, the market has recovered from pandemic losses. According to the American Society of Plastic Surgeons 2020 survey, 11% of respondents reported higher adoption of cosmetic surgery in 2021 and beyond.

The increasing number of weight loss surgeries is expected to propel the growth of the brachioplasty market. Brachioplasty is generally performed after weight loss surgery to maintain a consistent physical appearance by removing extra folds of skin and fat. For example, in May 2023, JAMA Pediatrics stated that weight loss procedures in teenagers increased by 20% in 2020-2021, while a 24% increase was seen in adults during the same period. In addition, medical researchers have found weight loss surgery to be a safe and effective treatment. Hence, increasing acceptance of weight loss surgeries will propel the market growth during the forecast period.

Moreover, the increasing association of self-esteem with physical appearance will drive the growth of the market. According to an article published by the Journal of Education and Health Promotion in August 2022, self-esteem was negatively associated with unhealthy weight in young adults. The increasing prevalence of geriatric population in developed countries is positively aiding the growth of the market. In addition, the American Academy of Dermatology stated that no serious complications were observed in elderly people who underwent cosmetic procedures. Body contouring procedures such as brachioplasty had improved procedural outcomes from the younger age group due to a better lifestyle. However, factors such as poor reimbursement policies and low awareness about the procedure are hindering the growth of the market.

Insights into the process

The surgical segment dominated the market and accounted for a revenue share of 75.20% in 2022. Arm lift surgery involves invasive techniques to remove excess tissue and fat. The growth can be attributed to established medical literature, long-term contour retention, and the effectiveness of brachioplasty surgeries. Additionally, according to an NCBI article published in June 2023, upper arm lift procedures recorded a 20% increase in 2019 from 2015. In addition, short scar brachioplasty is gaining tremendous traction due to its minimally invasive nature and reduced revision rates. scar.

The non-surgical segment is estimated to exhibit the fastest CAGR of 7.5% during the forecast period. The growth can be attributed to increasing technological advancements in energy-based devices to tighten upper arm tissues and reduce cellulite. In addition, these devices work harmoniously with other technologies. In addition, this process can be used in the initial stages of skin relaxation, thus increasing the use of the product.

End-use Insights

On the basis of end use, the brachioplasty market is segmented into hospitals and cosmetic surgery clinics. Cosmetic surgery clinics segment accounted for the highest revenue share of 63.47% in 2022 and is also expected to grow at the fastest CAGR of 7.5% during the forecast period. The segment’s growth can be attributed to the clinics’ specialized focus on aesthetics and beauty, higher provision of personalized care, shorter waiting times and lower risk of disease and infection.

Additionally, various long-term patient trial data confirm patient safety at these centers. According to the American Society of Plastic Surgeons, a complication rate of less than 1% was found in cosmetic procedures performed outside the hospital. Additionally, expanding facilities and introduction of technologically advanced clinics will provide lucrative opportunities in the market. For example, according to the National Institutes of Health, 82% of cosmetic procedures performed in the US in 2020 were performed at outpatient surgery centers.

Regional information

North America dominated the global brachioplasty market and accounted for a revenue share of 38.47% in 2022. The growth can be attributed to high population acceptance of cosmetic procedures, technological advancements in both surgical and non-surgical techniques, and accessibility and availability of skilled professionals. Additionally, increasing number of weight loss surgeries in the region is driving the market growth.

In recent decades, of Asia The aesthetic medicine market has developed very quickly. Asia Pacific is expected to register the fastest CAGR of 8.1% during the forecast period. The growth can be attributed to factors such as the growing importance of physical appearance, the increasing penetration of social media into lifestyles, and the advancement of healthcare infrastructure. Additionally, South Korea is considered a lucrative market for brachioplasty due to the availability of developed products and technologies. For example, it is estimated that 24% of all cosmetic procedures in the world are performed in South Korea.